Restricted accessResearch articleFirst published online 2025
Executive Function and Adherence in Children and Adolescents Living With HIV: Evidence From the HIV-Associated Neurocognitive Disorders in Zambia (HANDZ) Study
Executive function may be impaired in people with human immunodeficiency virus (HIV) infection, and poor executive function may affect medication adherence. However, there is little data on executive function in children and adolescents with perinatally acquired HIV in sub-Saharan Africa.
Methods
A total of 208 children/adolescents with perinatally acquired HIV and 208 HIV-exposed uninfected controls were recruited in Zambia for this prospective cohort study. Executive function was measured using performance-based, self-report, and parental report measures. Adherence over 1 year of follow-up was assessed through questionnaires and viral load measurement.
Results
Participants with HIV performed significantly worse on all 3 measures of executive function. Lower parental rating of executive function was associated with poorer antiretroviral therapy adherence (odds ratio 1.5, 95% confidence interval 1.02-2.2, P = .04).
Conclusion
Children and adolescents with perinatally acquired HIV have executive function impairments that may lead to consequences like poor medication adherence and treatment failure. Interventions to improve executive function or compensate for impaired executive function are needed in this population.
LastBSLawsonGMBreinerKSteinbergLFarahMJ. Childhood socioeconomic status and executive function in childhood and beyond. PLoS One. 2018;13:e0202964.
4.
Malloy-DinizLFMirandaDMDGrassi-OliveiraR. Executive Functions in Psychiatric Disorders. Frontiers Media SA; 2017.
5.
AntinoriAArendtGBeckerJT, et al.Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–1799.
6.
BoivinMJBarlow-MoshaLChernoffMC, et al.Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial. AIDS. 2018;32:189–204.
7.
BoivinMJChernoffMFairlieL, et al.African multi-site 2-year neuropsychological study of school-age children perinatally infected, exposed, and unexposed to human immunodeficiency virus. Clin Infect Dis. 2020;71:e105–e114.
8.
CoulehanKByrdDArentoftA, et al.The role of decision-making ability in HIV/AIDS: impact on prospective memory. J Clin Exp Neuropsychol. 2014;36:730–741.
9.
EzeamamaAEKizzaFNZalwangoSK, et al.Perinatal HIV status and executive function during school-age and adolescence: a comparative study of long-term cognitive capacity among children from a high HIV prevalence setting. Medicine (Baltimore). 2016;95:e3438.
10.
FamaRSullivanEVSassoonSAPfefferbaumAZahrNM. Impairments in component processes of executive function and episodic memory in alcoholism, HIV infection, and HIV infection with alcoholism comorbidity. Alcohol Clin Exp Res. 2016;40:2656–2666.
11.
González-AndradeAGarcía-TorresAPérez-GarcíaMVergara-MoraguesE. Assessment of executive functions as a measure of impairments in everyday functioning in persons with HIV. Psychol Health Med. 2022;27(7):1443-1449.
12.
HaaseVGNicolauNCVianaVNBarretoGVPintoJA. Executive function and processing speed in Brazilian HIV-infected children and adolescents. Dement Neuropsychol. 2014;8:32–39.
13.
KanmogneGDFonsahJYTangB, et al.Effects of HIV on executive function and verbal fluency in Cameroon. Sci Rep. 2018;8:17794.
14.
KerrSJPuthanakitTMaleeKM, et al.Increased risk of executive function and emotional behavioral problems among virologically well-controlled perinatally HIV-infected adolescents in Thailand and Cambodia. J Acquir Immune Defic Syndr. 2019;82:297–304.
15.
LaughtonBCornellMBoivinMVan RieA. Neurodevelopment in perinatally HIV-infected children: a concern for adolescence. J Int AIDS Soc. 2013;16:18603.
16.
LentoorAG. Clinico-immunological status and neurocognitive function of perinatally acquired HIV-positive children on cART: a cross-sectional correlational study in South Africa. Front Neurol. 2020;11:243.
17.
LewBJMcDermottTJWiesmanAI, et al.Neural dynamics of selective attention deficits in HIV-associated neurocognitive disorder. Neurology. 2018;91:e1860–e1869.
18.
LlorenteAMBrouwersPLeightyR, et al.An analysis of select emerging executive skills in perinatally HIV-1-infected children. Appl Neuropsychol Child. 2014;3:10–25.
19.
MaleeKMChernoffMCSiroisPA, et al.Impact of perinatally acquired HIV disease upon longitudinal changes in memory and executive functioning. J Acquir Immune Defic Syndr. 2017;75:455–464.
20.
McHenryMSMcAteerCIOyunguE, et al.Neurodevelopment in young children born to HIV-infected mothers: a meta-analysis. Pediatrics. 2018;141:e20172888.
21.
MilliganRCockcroftK. Working memory profiles in HIV-exposed, uninfected and HIV-infected children: a comparison with neurotypical controls. Front Hum Neurosci. 2017;11:348.
22.
MintzM. Neurological and developmental problems in pediatric HIV infection. J Nutr. 1996;126:2663S–2673S.
23.
MoranLMBoozeRMMactutusCF. Modeling deficits in attention, inhibition, and flexibility in HAND. J Neuroimmune Pharmacol. 2014;9:508–521.
24.
NicholsSMahoneyEMSiroisPA, et al.HIV-associated changes in adaptive, emotional, and behavioral functioning in children and adolescents with hemophilia: results from the hemophilia growth and development study. J Pediatr Psychol. 2000;25:545–556.
25.
NicholsSLBrummelSSSmithRA, et al.Executive functioning in children and adolescents with perinatal HIV infection. Pediatr Infect Dis J. 2015;34:969–975.
26.
NicholsSLChernoffMCMaleeKM, et al.Executive functioning in children and adolescents with perinatal HIV infection and perinatal HIV exposure. J Pediatric Infect Dis Soc. 2016;5:S15–S23.
27.
OkawaSMwanza KabagheSMwiyaM, et al.Psychological well-being and adherence to antiretroviral therapy among adolescents living with HIV in Zambia. AIDS Care. 2018;30:634–642.
28.
PatelPBBeldenAHandokoR, et al.Behavioral impairment and cognition in Thai adolescents affected by HIV. Glob Ment Health (Camb). 2021;8:e3.
29.
PuthanakitTAurpibulLLouthrenooO, et al.Poor cognitive functioning of school-aged children in Thailand with perinatally acquired HIV infection taking antiretroviral therapy. AIDS Patient Care STDS. 2010;24:141–146.
30.
RegerMWelshRRazaniJMartinDJBooneKB. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc. 2002;8:410–424.
31.
RoweKBuivydaiteRHeinsohnT, et al.Executive function in HIV-affected children and adolescents: a systematic review and meta-analyses. AIDS Care. 2021:1–25.
32.
WalkerKABrownGG. HIV-associated executive dysfunction in the era of modern antiretroviral therapy: a systematic review and meta-analysis. J Clin Exp Neuropsychol. 2018;40:357–376.
33.
SmithRWilkinsM. Perinatally acquired HIV infection: long-term neuropsychological consequences and challenges ahead. Child Neuropsychol. 2015;21:234–268.
34.
ThakurKTBoubourASaylorDDasMBeardenDRBirbeckGL. Global HIV neurology: a comprehensive review. AIDS. 2019;33:163–184.
35.
WilmshurstJMHammondCKDonaldKHoareJCohenKEleyB. NeuroAIDS in children. Handb Clin Neurol. 2018;152:99–116.
36.
BeardenDRCicconeOPatelAA. Global health: pediatric neurology. Semin Neurol. 2018;38:200–207.
37.
PhillipsNAmosTKuoC, et al.HIV-associated cognitive impairment in perinatally infected children: a meta-analysis. Pediatrics. 2016;138:e20160893.
38.
SmithRChernoffMWilliamsPL, et al.Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence. Pediatr Infect Dis J. 2012;31:592–598.
39.
RubinLHMakiPM. HIV, depression, and cognitive impairment in the era of effective antiretroviral therapy. Curr HIV/AIDS Rep. 2019;16:82–95.
40.
CohenRASiegelSGullettJM, et al.Neural response to working memory demand predicts neurocognitive deficits in HIV. J Neurovirol. 2018;24:291–304.
41.
CysiqueLAMaruffPBrewBJ. The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis. J Int Neuropsychol Soc. 2006;12:368–382.
42.
FoleyJEttenhoferMWrightMHinkinCH. Emerging issues in the neuropsychology of HIV infection. Curr HIV/AIDS Rep. 2008;5:204–211.
43.
HeatonRKFranklinDREllisRJ, et al.HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3–16.
44.
ContardoCBlackACBeauvaisJDieckhausKRosenMI. Relationship of prospective memory to neuropsychological function and antiretroviral adherence. Arch Clin Neuropsychol. 2009;24:547–554.
45.
HinkinCHCastellonSADurvasulaRS, et al.Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59:1944–1950.
46.
HinkinCHHardyDJMasonKI, et al.Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(suppl 1):S19–S25.
47.
InselKMorrowDBrewerBFigueredoA. Executive function, working memory, and medication adherence among older adults. J Gerontol B Psychol Sci Soc Sci. 2006;61:P102–P107.
48.
ObermeitLCMorganEECasalettoKBGrantIWoodsSP, HIV NRPG. Antiretroviral non-adherence is associated with a retrieval profile of deficits in verbal episodic memory. Clin Neuropsychol. 2015;29:197–213.
49.
StilleyCSBenderCMDunbar-JacobJSereikaSRyanCM. The impact of cognitive function on medication management: three studies. Health Psychol. 2010;29:50–55.
50.
ZoggJBWoodsSPWeberE, et al.HIV-associated prospective memory impairment in the laboratory predicts failures on a semi-naturalistic measure of health care compliance. Clin Neuropsychol. 2010;24:945–962.
51.
GarviePABrummelSSAllisonSM, et al.Roles of medication responsibility, executive and adaptive functioning in adherence for children and adolescents with perinatally acquired HIV. Pediatr Infect Dis J. 2017;36:751–757.
52.
ArmstrongANagataJMVicariM, et al.A global research agenda for adolescents living with HIV. J Acquir Immune Defic Syndr. 2018;78(suppl 1):S16–S21.
53.
MbalindaSNBakeera-KitakaSLusotaDAMagongoENMusokePKayeDK. Barriers and facilitators for transitioning of young people from adolescent clinics to adult ART clinics in Uganda: unintended consequences of successful adolescent ART clinics. BMC Health Serv Res. 2020;20:835.
54.
MeloniSTAgabaPChangCA, et al.Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria. PLoS One. 2020;15:e0236801.
55.
MohammedPLindenAReillyM. Quantifying pediatric patient need for second- and third-line HIV treatment: a tool for decision-making in resource-limited settings. PLoS One. 2019;14:e0224226.
56.
TadesseBTFosterBALatourE, et al.Predictors of virologic failure among a cohort of HIV-infected children in southern Ethiopia. Pediatr Infect Dis J. 2021;40:60–65.
57.
AdamsHRMwanza-KabagheSMbeweEG, et al.The HIV-Associated Neurocognitive Disorders in Zambia (HANDZ) Study: protocol of a research program in pediatric HIV in sub-Saharan Africa. medRxiv. 2019; 19003590.
58.
DeanOBudaAAdamsHR, et al.Brain magnetic resonance imaging findings associated with cognitive impairment in children and adolescents with human immunodeficiency virus in Zambia. Pediatr Neurol. 2020;102:28–35.
59.
MolinaroMAdamsHRMwanza-KabagheS, et al.Evaluating the relationship between depression and cognitive function among children and adolescents with HIV in Zambia. AIDS Behav. 2021;25:2669-2679.
60.
SchneiderCLMohajeri-MoghaddamSMbeweEG, et al.Cerebrovascular disease in children perinatally infected with human immunodeficiency virus in Zambia. Pediatr Neurol. 2020;112:14–21.
61.
BudaADeanOAdamsHR, et al.Neighborhood-based socioeconomic determinants of cognitive impairment in Zambian children with HIV: a quantitative geographic information systems approach. J Pediatric Infect Dis Soc. 2021;10:1071-1079.
62.
MbeweEGKabundulaPPMwanza-KabagheS, et al.Socioeconomic status and cognitive function in children with HIV: evidence from the HIV-Associated Neurocognitive Disorders in Zambia (HANDZ) study. J Acquir Immune Defic Syndr.2022;89:56–63.
63.
. World Health Organization. WHO Child Growth Standards: Length/Height-for-Age, Weight-for-Age, Weight-for-Length, Weight-for-Height and Body Mass Index-for-Age: Methods and Development. World Health Organization; 2006.
64.
GioiaGAIsquithPKGuySCKenworthyL. Test review behavior rating inventory of executive function. Child Neuropsychol.2000;6:235–238.
65.
ChernoffMCLaughtonBRatswanaM, et al.Validity of neuropsychological testing in young African children affected by HIV. J Pediatr Infect Dis. 2018;13:185–201.
66.
AkshoomoffNNewmanEThompsonWK, et al.The NIH Toolbox Cognition Battery: results from a large normative developmental sample (PING). Neuropsychology. 2014;28:1–10.
67.
HesslDSansoneSMBerry-KravisE, et al.The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions. J Neurodev Disord. 2016;8:35.
68.
TulskyDSHeinemannAW. The clinical utility and construct validity of the NIH Toolbox Cognition Battery (NIHTB-CB) in individuals with disabilities. Rehabil Psychol. 2017;62:409–412.
69.
ZelazoPDAndersonJERichlerJWallner-AllenKBeaumontJLWeintraub IIS. NIH Toolbox Cognition Battery (CB): measuring executive function and attention. Monogr Soc Res Child Dev. 2013;78:16–33.
70.
ZelazoPDAndersonJERichlerJ, et al.NIH Toolbox Cognition Battery (CB): validation of executive function measures in adults. J Int Neuropsychol Soc. 2014;20:620–629.
71.
TassiopoulosKPatelKAlperenJ, et al.Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP up, a prospective cohort study. BMJ Open. 2016;6:e011396.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
